At a glance
- What the study gets you
- Health checks and monitoring — no treatment given
- Type of study
- Observational (no treatment given)
- Time in hospital
- In-person visits at study sites — visit count not specified by the sponsor
- Drug or intervention
- Patient Registry (other)
- How long the study runs
- Study runs about 211 months (dates as stated)
- About the drug or intervention
- Patient Registry — other: Participants who have volunteered to participate will complete various questionnaires relating to their condition.
- Patient visit burden
- Not specified by the sponsor
- Type of study
- Observing health over time
- Ages
- Not specified
- Who
- All
- Number of participants
- 900
- Started
- 2013-05
- Last checked
- 2026-10
Plain English Summary
What is this study?
- • Testing a new treatment for myotonic dystrophy
- • Clinical study - 900 participants
- • Myotonic dystrophy (dystrophia myotonica - DM) exists in two forms, usually referred to as DM1 (type 1) and DM2 (type 2)
Who can take part?
- • Adults
- • Diagnosed with myotonic dystrophy
Where?
- • Newcastle upon Tyne - John Walton Muscular Dystrophy Research Centre
This is a simplified summary. Always discuss with your doctor before making any decisions.
About This Trial
Myotonic dystrophy (dystrophia myotonica - DM) exists in two forms, usually referred to as DM1 (type 1) and DM2 (type 2). Both conditions are genetic disorders but each affects a different gene. DM1 is the most common adult-onset muscular dystrophy, and is thought to affect at least 1 in 8,000 people worldwide. The aim is to facilitate a questionnaire based research study in order to better characterise and understand the disease in the UK. By maintaining a national registry this will help identify potential participants eligible for clinical trials in the future.
More detail
The UK DM Patient Registry (https://www.dm-registry.org/uk/) aims to recruit any individual, from anywhere within the United Kingdom, with a diagnosis of myotonic dystrophy. Participants may be referred to the registry by health care professionals, or genetic testing/laboratory centres who are aware of the registry. Alternatively, a participant may have discovered the registry via promotional activities or by their own online searches. After completing the consent process, participants are able to enter information on to the registry platform (note all forms are also available offline as well). This is an ongoing database and all participants will invited to update their information on an annual basis. The registry is sponsored by Muscular Dystrophy UK, Cure-DM and the Myotonic Dystrophy Support Group. The database is divided into two main sections: 1. Mandatory items (demographic information, clinical diagnosis, genetic test result, current best motor function and wheelchair use) and 2. Highly encouraged items (severity of muscle symptoms, cardiac status, respiratory function, digestion, cataracts, and fatigue, ethnic origin and data on involvement with other registries) The database is designed to be self reporting, however where specialised clinical or genetic information is required, the neuromuscular specialist in charge of the participants care can be invited to provide some additional information. The participant is able to select a health care provider from a pre-populated list at registration stage, if they wish to (optional feature). This information is included in the patient information and consent.
How this trial compares with your answers
Answer 2 more questions to improve match
What we know so far
Still need:
- • Tell us your age for better matching
- • Tell us your sex for better matching
Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.
Eligibility at a Glance
Key info
- Age: Not specified
- Who can join: All genders
What the study is looking for
- ✓All patients with a confirmed Myotonic Dystrophy diagnosis (or pending diagnosis) are eligible for inclusion....
Who cannot take part
- ✗There are no exclusion criteria for the registry
See the full criteria
Where Is This Study? (1 UK site)
John Walton Muscular Dystrophy Research Centre
Newcastle upon Tyne NE1 3BZ, United Kingdom
How to Get in Touch
Registry Curator
Sponsor contactCONTACT
